K. Limaye, Andrew B. Koo, A. Havenon, S. A. Kasab, B. Bohnstedt, I. Maier, M. Psychogios, S. Wolfe, A. Arthur, Peter T Kan, Joon-Tae Kim, R. Leacy, J. Osbun, A. Rai, P. Jabbour, M. Park, R. Crosa, J. Mascitelli, M. Levitt, A. Polifka, W. Casagrande, S. Yoshimura, R. Williamson, B. Gory, M. Mokin, Isabel Fragata, D. Romano, S. Chowdry, A. Shaban, M. Moss, D. Behme, A. Spiotta, C. Matouk
{"title":"延迟时间窗MCA - M2取栓的安全性和有效性:来自STAR注册的倾向评分分析","authors":"K. Limaye, Andrew B. Koo, A. Havenon, S. A. Kasab, B. Bohnstedt, I. Maier, M. Psychogios, S. Wolfe, A. Arthur, Peter T Kan, Joon-Tae Kim, R. Leacy, J. Osbun, A. Rai, P. Jabbour, M. Park, R. Crosa, J. Mascitelli, M. Levitt, A. Polifka, W. Casagrande, S. Yoshimura, R. Williamson, B. Gory, M. Mokin, Isabel Fragata, D. Romano, S. Chowdry, A. Shaban, M. Moss, D. Behme, A. Spiotta, C. Matouk","doi":"10.1161/svin.122.000664","DOIUrl":null,"url":null,"abstract":"\n \n Mechanical thrombectomy of middle cerebral artery M2 segment occlusion of the middle cerebral artery has reported safety and efficacy in recent post‐hoc and observational studies. However, there is no known benefit of mechanical thrombectomy for patients with M2 segment occlusions in the delayed time window (>6 hours).\n \n \n \n The Stroke Thrombectomy and Aneurysm Registry (STAR) is a prospective, multicenter, nonrandomized observational study registry for acute ischemic stroke thrombectomy and aneurysm treatment. We analyzed all patients who underwent mechanical thrombectomy within the late time window (>6 hours from symptom onset) involving isolated M2 occlusions. We used propensity score matching to select a comparison group of patients who underwent mechanical thrombectomy for M1 occlusion in the same time window.\n \n \n \n \n Of 1083 consecutive patients analyzed, propensity matching yielded 180 well matched M1 and M2 pairs. Baseline demographics were well balanced between the groups (M1 and M2). Alberta stroke program early CT score (7.6±1.7 versus 8.3±1.5;\n P\n <0.001) was higher in the M2 group. There was a trend towards less complete recanalization (Thrombolysis in Cerebral Infarction 3) 46.1% versus 39.9% (\n P\n =0.053) in the middle cerebral artery M2 segment cohort. However, successful recanalization (Thrombolysis in Cerebral Infarction 2b‐3) was better in middle cerebral artery M2 segment cohort (85% versus 90.5%;\n P\n =0.053). Postprocedural asymptomatic hemorrhage rates were similar (29.4% versus 27.8%;\n P\n =0.816), but symptomatic hemorrhage rates were higher in the M1 group (7.2% versus 2.2%;\n P\n =0.047). Rates of good clinical outcome (modified Rankin scale 0–2) were similar at final follow‐up (43.9% versus 46.7%;\n P\n =0.672). The overall mortality was also similar between the cohorts (12.8% versus 13.9%;\n P\n =0.877).\n \n \n \n \n In our analysis of the Stroke Thrombectomy and Aneurysm Registry, M2 occlusions not only achieved similar rates of recanalization and good functional outcome compared with M1 occlusions in a delayed time window (6–24 hours from last normal) but also had less symptomatic intracranial hemorrhage.\n","PeriodicalId":74875,"journal":{"name":"Stroke (Hoboken, N.J.)","volume":"1 1","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2023-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Safety and Efficacy of MCA‐M2 Thrombectomy in Delayed Time Window: A Propensity Score Analysis From the STAR Registry\",\"authors\":\"K. Limaye, Andrew B. Koo, A. Havenon, S. A. Kasab, B. Bohnstedt, I. Maier, M. Psychogios, S. Wolfe, A. Arthur, Peter T Kan, Joon-Tae Kim, R. Leacy, J. Osbun, A. Rai, P. Jabbour, M. Park, R. Crosa, J. Mascitelli, M. Levitt, A. Polifka, W. Casagrande, S. Yoshimura, R. Williamson, B. Gory, M. Mokin, Isabel Fragata, D. Romano, S. Chowdry, A. Shaban, M. Moss, D. Behme, A. Spiotta, C. Matouk\",\"doi\":\"10.1161/svin.122.000664\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n \\n Mechanical thrombectomy of middle cerebral artery M2 segment occlusion of the middle cerebral artery has reported safety and efficacy in recent post‐hoc and observational studies. However, there is no known benefit of mechanical thrombectomy for patients with M2 segment occlusions in the delayed time window (>6 hours).\\n \\n \\n \\n The Stroke Thrombectomy and Aneurysm Registry (STAR) is a prospective, multicenter, nonrandomized observational study registry for acute ischemic stroke thrombectomy and aneurysm treatment. We analyzed all patients who underwent mechanical thrombectomy within the late time window (>6 hours from symptom onset) involving isolated M2 occlusions. We used propensity score matching to select a comparison group of patients who underwent mechanical thrombectomy for M1 occlusion in the same time window.\\n \\n \\n \\n \\n Of 1083 consecutive patients analyzed, propensity matching yielded 180 well matched M1 and M2 pairs. Baseline demographics were well balanced between the groups (M1 and M2). Alberta stroke program early CT score (7.6±1.7 versus 8.3±1.5;\\n P\\n <0.001) was higher in the M2 group. There was a trend towards less complete recanalization (Thrombolysis in Cerebral Infarction 3) 46.1% versus 39.9% (\\n P\\n =0.053) in the middle cerebral artery M2 segment cohort. However, successful recanalization (Thrombolysis in Cerebral Infarction 2b‐3) was better in middle cerebral artery M2 segment cohort (85% versus 90.5%;\\n P\\n =0.053). Postprocedural asymptomatic hemorrhage rates were similar (29.4% versus 27.8%;\\n P\\n =0.816), but symptomatic hemorrhage rates were higher in the M1 group (7.2% versus 2.2%;\\n P\\n =0.047). Rates of good clinical outcome (modified Rankin scale 0–2) were similar at final follow‐up (43.9% versus 46.7%;\\n P\\n =0.672). The overall mortality was also similar between the cohorts (12.8% versus 13.9%;\\n P\\n =0.877).\\n \\n \\n \\n \\n In our analysis of the Stroke Thrombectomy and Aneurysm Registry, M2 occlusions not only achieved similar rates of recanalization and good functional outcome compared with M1 occlusions in a delayed time window (6–24 hours from last normal) but also had less symptomatic intracranial hemorrhage.\\n\",\"PeriodicalId\":74875,\"journal\":{\"name\":\"Stroke (Hoboken, N.J.)\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2023-03-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Stroke (Hoboken, N.J.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1161/svin.122.000664\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stroke (Hoboken, N.J.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1161/svin.122.000664","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
在最近的事后和观察性研究中,大脑中动脉M2段闭塞的机械取栓术已经报道了安全性和有效性。然而,对于延迟时间窗(bbb6小时)的M2段闭塞患者,机械取栓并没有已知的益处。卒中血栓切除术和动脉瘤登记(STAR)是一项前瞻性、多中心、非随机观察性研究,用于急性缺血性卒中血栓切除术和动脉瘤治疗。我们分析了所有在晚时间窗(症状出现后6小时)内进行机械取栓的患者,包括孤立的M2闭塞。我们使用倾向评分匹配法选择在同一时间窗内接受机械取栓治疗M1闭塞的患者作为对照组。在1083例连续分析的患者中,倾向匹配产生了180对匹配良好的M1和M2对。基线人口统计数据在各组(M1和M2)之间很好地平衡。阿尔伯塔卒中项目早期CT评分(7.6±1.7比8.3±1.5);P <0.001), M2组较高。在大脑中动脉M2段队列中,再通不完全的趋势(脑梗死3期溶栓)为46.1%比39.9% (P =0.053)。然而,在大脑中动脉M2段队列中,成功的再通(脑梗死2b‐3溶栓)更好(85%对90.5%;P = 0.053)。术后无症状出血率相似(29.4% vs 27.8%;P =0.816),但M1组的症状性出血率更高(7.2%比2.2%;P = 0.047)。在最终随访时,良好临床转归率(改良Rankin量表0-2)相似(43.9% vs 46.7%;P = 0.672)。队列之间的总体死亡率也相似(12.8%对13.9%;P = 0.877)。在我们对脑卒中取栓和动脉瘤登记的分析中,与M1闭塞相比,M2闭塞不仅在延迟的时间窗(距离上一次正常6-24小时)内实现了相似的再通率和良好的功能结果,而且症状性颅内出血也更少。
Safety and Efficacy of MCA‐M2 Thrombectomy in Delayed Time Window: A Propensity Score Analysis From the STAR Registry
Mechanical thrombectomy of middle cerebral artery M2 segment occlusion of the middle cerebral artery has reported safety and efficacy in recent post‐hoc and observational studies. However, there is no known benefit of mechanical thrombectomy for patients with M2 segment occlusions in the delayed time window (>6 hours).
The Stroke Thrombectomy and Aneurysm Registry (STAR) is a prospective, multicenter, nonrandomized observational study registry for acute ischemic stroke thrombectomy and aneurysm treatment. We analyzed all patients who underwent mechanical thrombectomy within the late time window (>6 hours from symptom onset) involving isolated M2 occlusions. We used propensity score matching to select a comparison group of patients who underwent mechanical thrombectomy for M1 occlusion in the same time window.
Of 1083 consecutive patients analyzed, propensity matching yielded 180 well matched M1 and M2 pairs. Baseline demographics were well balanced between the groups (M1 and M2). Alberta stroke program early CT score (7.6±1.7 versus 8.3±1.5;
P
<0.001) was higher in the M2 group. There was a trend towards less complete recanalization (Thrombolysis in Cerebral Infarction 3) 46.1% versus 39.9% (
P
=0.053) in the middle cerebral artery M2 segment cohort. However, successful recanalization (Thrombolysis in Cerebral Infarction 2b‐3) was better in middle cerebral artery M2 segment cohort (85% versus 90.5%;
P
=0.053). Postprocedural asymptomatic hemorrhage rates were similar (29.4% versus 27.8%;
P
=0.816), but symptomatic hemorrhage rates were higher in the M1 group (7.2% versus 2.2%;
P
=0.047). Rates of good clinical outcome (modified Rankin scale 0–2) were similar at final follow‐up (43.9% versus 46.7%;
P
=0.672). The overall mortality was also similar between the cohorts (12.8% versus 13.9%;
P
=0.877).
In our analysis of the Stroke Thrombectomy and Aneurysm Registry, M2 occlusions not only achieved similar rates of recanalization and good functional outcome compared with M1 occlusions in a delayed time window (6–24 hours from last normal) but also had less symptomatic intracranial hemorrhage.